The University of Queensland (UQ) has entered a three-year collaboration with Denmark-based pharmaceutical company LEO Pharma with the aim of delivering new treatment options to patients suffering from skin cancer. [ + ]

Clinical Genomics - the developer of a blood-based biomarker test in collaboration with CSIRO Preventative Health Flagship and the Flinders Centre for Innovation in Cancer - has acquired US-based screening company Enterix from Quest Diagnostics, as well as its Sydney-based subsidiary. [ + ]

After a positive meeting with the US FDA, QRxPharma (ASX:QRX) aims to resubmit its application for approval of pain drug MoxDuo in mid-November. [ + ]

Orthocell's results from a clinical study of its Ortho-ATI technology for regenerating damaged tendons have been published in The American Journal of Sports Medicine. [ + ]

Eight surgeons, based at The Prince Charles Hospital in Brisbane, were today approved to use Allied Healthcare's (ASX: AHZ) CardioCel to repair and treat heart defects in adult patients under the Authorised Prescriber Scheme (APS). [ + ]

Bionomics (ASX:BNO) has received additional decisions from Innovation Australia in relation to the company's applications for an advance finding under the R&D Tax Incentive. [ + ]

Laboratory and pharmaceutical equipment provider Sartorius Stedim Biotech has made a cash offer to acquire UK company TAP Biosystems through its wholly owned subsidiary, Sartorius Stedim Biotech GmbH. [ + ]

UK-headquartered contract organisation TranScrip Partners has opened a new office in Hong Kong. This follows recent openings in Australia and the US and is underpinned by the continuing increase of contracts in the Asia-Pacific region. [ + ]

Three scientists' work on a major transport system in cells has won them the 2013 Nobel Prize in Physiology or Medicine. [ + ]

In a major coup for the biotechnology industry and Australia, the International Biotechnology Symposium (IBS), a premier international conference in the rapidly growing field of biotechnology, is heading to Melbourne in 2016. [ + ]

ResMed (ASX:RMD) has nominated US health sector veteran Carol J Burt to take long-serving director Michael Quinn's place on the board once his final term expires. [ + ]

Genetic Technologies (ASX:GTG) has completed the SPP stage of its capital raising and revealed that underwriter Cygnetl has committed to buy an extra $1m worth of shares. [ + ]

Microbiologists from Flinders University in Adelaide and the Weizmann Institute of Science (WIS) in Israel are teaming up to study how bacteria become resistant to antibiotics. [ + ]

Queensland's key health research institutes have joined forces to create the Queensland Mental Health Research Alliance. [ + ]

Dr Peter Smith, former CEO of Alchemia (ASX:ACL), has joined Ascend Biopharmaceuticals as its board chairman. [ + ]